$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
028-123456789
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
medicaldrugs
medicaldrugs
Differences and options between midostaurin and gilitinib in the treatment of leukemia
2026-02-01 22:25:32
Check Details
Is Cabergoline safe for long-term use and its potential effects on the body?
2026-02-01 22:25:32
Check Details
What kind of drugs does Momelotinib belong to and its role in blood diseases?
2026-02-01 22:25:32
Check Details
What kind of drug is Bikken Pronol Tablets (Bituowei) and analysis of its main indications
2026-02-01 22:25:32
Check Details
Analysis of the main efficacy and clinical therapeutic effects of deuterated colexitinib (decavatinib)
2026-02-01 22:25:32
Check Details
Safety and precautions for using Apremilast (Otelor) in children and special groups
2026-02-01 22:25:32
Check Details
Analysis of common adverse reactions and occurrence probability of Valganciclovir
2026-02-01 22:25:32
Check Details
How long is the validity period of Axitinib (Inlida) and the effects of improper storage?
2026-02-01 22:25:32
Check Details
Treatment methods and scientific mitigation measures for adverse reactions of Trametinib (Megenin)
2026-02-01 22:25:32
Check Details
Description of the domestic marketing and approval status of Avatrombopag
2026-02-01 22:25:32
Check Details
Is Erlotinib/Tarceva a targeted drug?
2026-02-01 22:25:32
Check Details
Tofacitinib/Shangjie and UVB combination shows promise in treating vitiligo
2026-02-01 22:25:32
Check Details
1
2
...
2208
2209
2210
2211
2212
2213
2214
...
2438
2439
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
User Agreement
2
Herceptin Hylecta treats HER2-positive breast cancer and only needs to be injected subcutaneously and only used once every three weeks
3
What is the most important information I should know about WELIREG?
4
How to take and store WELIREG
5
How to take TRUSELTIQ correctly
6
How to deal with LONSURF side effects (1)
7
How to deal with LONSURF side effects (2)
8
Cabozantinib (Cabometyx)-new indication approved
9
What should I pay attention to when using atezolizumab/Tecentriq?
10
Darzalex Faspro, Kyprolis and dexamethasone "three swords combined" to treat multiple myeloma
11
Rituximab combined with chemotherapy approved in the United States for pediatric patients with specific malignant tumors
12
Lenvatinib and pembrolizumab trial results in unresectable hepatocellular carcinoma